Mastitis (Lactational)

1. Clinical Overview

Summary

Lactational mastitis is an inflammatory condition of the breast tissue that occurs predominantly during breastfeeding, representing a clinical spectrum from non-infectious milk stasis (blocked duct) through infectious mastitis (bacterial invasion) to breast abscess formation. It affects approximately 10-33% of breastfeeding women and is a leading cause of premature cessation of breastfeeding. [1,2,3]

The condition is characterized by localized breast pain, erythema, swelling, and systemic symptoms including fever and malaise. The cornerstone of management across all stages remains effective milk removal through continued breastfeeding or expression. [4,5]

The Academy of Breastfeeding Medicine has revised the terminology to describe a "mastitis spectrum" recognizing that inflammation may occur without infection, and that the transition from one stage to another is not always linear or predictable. [4]

Key Clinical Principles

1. The Cardinal Rule: "Don't Stop Feeding" Effective milk removal is the primary therapeutic intervention for all stages of the mastitis spectrum. Cessation of breastfeeding leads to milk stasis, increased intramammary pressure, and progression to abscess formation. [4,5]

2. The Spectrum Concept Modern understanding recognizes that mastitis exists on a continuum:

• Ductal Narrowing/Milk Stasis → Blocked duct, no systemic symptoms
• Inflammatory Mastitis → Local inflammation, may have fever, sterile milk culture
• Bacterial Mastitis → Bacterial invasion, positive milk culture, systemic symptoms
• Abscess Formation → Walled-off collection, fluctuance, requires drainage [4]

3. The Microbiome Paradigm Recent research has shifted understanding from simple bacterial infection to dysbiosis of the breast microbiome. The healthy lactating breast is not sterile but contains a diverse bacterial community. Mastitis may represent overgrowth of pathogenic species (particularly Staphylococcus aureus) rather than de novo infection. [6,7]

Clinical Pearls

The "Fluclox" Rule: The causative organism in bacterial mastitis is almost always Staphylococcus aureus (from skin flora or infant nasopharynx). Therefore, empiric antibiotic therapy must provide anti-staphylococcal coverage. Flucloxacillin is the first-line agent in the UK and Australia; dicloxacillin in the USA. Amoxicillin or ampicillin alone are ineffective due to beta-lactamase production by S. aureus. [1,4]

Needle vs Knife: For breast abscess, the gold standard is ultrasound-guided needle aspiration with or without drain placement, NOT incision and drainage (I&D). Needle aspiration allows continuation of breastfeeding, avoids scarring, prevents milk fistula formation, and has equivalent or superior cure rates. I&D should be reserved for complex or multiloculated abscesses not amenable to aspiration. [8,9]

The 48-72 Hour Rule: Clinical improvement should be evident within 48-72 hours of appropriate antibiotic therapy. Failure to improve mandates reassessment: consider resistant organisms (MRSA), abscess formation, or inflammatory breast cancer masquerading as mastitis. [1,4]

Inflammatory Cancer Mimic: Inflammatory breast cancer (IBC) classically presents with breast erythema, peau d'orange, and systemic symptoms that can mimic mastitis. Any "mastitis" that fails to resolve after a complete course of antibiotics, occurs in a non-lactating woman, or presents bilaterally requires urgent imaging (mammography and ultrasound) and consideration of biopsy. [10]

---

2. Epidemiology

Incidence and Prevalence

• Overall Incidence: Affects 10-33% of breastfeeding women, with most studies reporting rates around 20%. [2,3]
• Cumulative Risk: The lifetime risk during any breastfeeding episode is approximately 1 in 5 women.
• Global Variation: Incidence varies by region, with higher rates reported in some Australian cohorts (33%) compared to European studies (10-20%). [2]

Timing

• Peak Incidence: Most common in the first 12 weeks postpartum, with highest risk in weeks 2-4 when lactation is establishing and milk supply is transitioning. [1,2]
• Late Presentation: Can occur at any time during lactation, including during weaning when milk stasis is common.
• Primiparity: Higher incidence in first-time mothers (odds ratio 1.7-2.0) related to inexperience with breastfeeding technique. [3]

Recurrence

• Recurrence Rate: 5-10% of women experience recurrent episodes. [1]
• Predictors of Recurrence: Incomplete treatment (antibiotic course less than 10 days), persistent mechanical factors (poor latch, tongue tie), and possibly host immune factors. [11]

Risk Factors

Maternal Factors

• Nipple Trauma: Cracks, fissures, or bleeding nipples provide portal of entry for bacteria (odds ratio 2.0-3.0). [3]
• Previous Mastitis: History of mastitis in a prior lactation increases risk (OR 2.4). [3]
• Maternal Stress and Fatigue: Sleep deprivation, psychosocial stress, and return to work are associated with increased risk. [12]
• Diabetes Mellitus: Both pre-existing and gestational diabetes increase infection risk.
• Immunosuppression: HIV, chronic corticosteroid use, or other immunocompromise.
• Obesity: BMI > 30 associated with increased risk (OR 1.8). [3]

Breastfeeding Factors

• Ineffective Milk Removal:
  • Poor latch or positioning
  • Infrequent feeding or abrupt decrease in feeding frequency
  • Oversupply or hyperlactation
  • Infant tongue tie (ankyloglossia) or other oral anatomical variants
• Rapid Weaning: Abrupt cessation or rapid decrease in feeding frequency
• Prolonged Intervals: Sleeping through feeds, return to work, or use of pacifiers leading to missed feeds

Mechanical Factors

• External Pressure:
  • Tight or underwired bras
  • Car seatbelt pressure
  • Prone sleeping position
  • Heavy shoulder bags
• Blocked Ducts: Dried milk at nipple pore ("milk blister" or bleb), thickened milk, or anatomical duct narrowing

Infant Factors

• Colonization: Infant nasopharyngeal or skin colonization with S. aureus increases maternal risk. [6]
• Oral Candidiasis: May predispose to nipple trauma and secondary bacterial infection.

---

3. Pathophysiology

The Mastitis Spectrum: A Continuum Model

The current understanding, as articulated in the Academy of Breastfeeding Medicine Protocol #36 (2022), views mastitis as a spectrum rather than discrete entities. [4]

Stage 1: Ductal Narrowing and Milk Stasis

Mechanism: Incomplete emptying of a breast segment leads to milk accumulation and increased intraluminal pressure.

Causes:

• Mechanical obstruction (dried milk plug, thickened secretions)
• External compression (tight clothing, positioning)
• Missed or ineffective feeds

Pathology: Distended alveoli and ducts, epithelial compression, no inflammatory infiltrate.

Clinical: Focal lump, minimal erythema, no systemic symptoms, no fever.

Stage 2: Inflammatory (Non-infectious) Mastitis

Mechanism: Milk leakage from distended ducts into periductal and interstitial tissue triggers an immune response.

Inflammatory Cascade:

1. Milk proteins (particularly casein and whey proteins) act as antigens
2. Activation of tissue macrophages and mast cells
3. Release of pro-inflammatory cytokines (IL-1β, IL-6, IL-8, TNF-α)
4. Recruitment of neutrophils and lymphocytes
5. Increased vascular permeability → edema, erythema
6. Systemic cytokine effects → fever, malaise, myalgias [13]

Pathology: Interstitial edema, perivascular inflammatory infiltrate (lymphocytes, plasma cells), intact epithelium, sterile milk.

Clinical: Wedge-shaped area of erythema and tenderness, fever, flu-like symptoms, milk culture negative or low bacterial counts.

Stage 3: Bacterial (Infectious) Mastitis

Mechanism: Bacterial invasion and multiplication within stagnant milk and inflamed tissue.

Bacterial Etiology:

• Primary Pathogen: Staphylococcus aureus (60-80% of cases)

  • "Source: Maternal skin flora, infant oral/nasal colonization"
  • "Virulence factors: Coagulase, protein A, enterotoxins"
  • Forms biofilms within ducts, impeding immune clearance [6,7]

• Other Organisms:

  • "Coagulase-negative staphylococci (S. epidermidis): 10-20%"
  • "Streptococcus species (particularly S. agalactiae, S. pyogenes): 5-10%"
  • "Methicillin-resistant S. aureus (MRSA): Increasing in hospital-acquired cases and regions with high community MRSA prevalence [14]"
  • "Rare: Corynebacterium, Enterococcus, anaerobes"

Portal of Entry:

1. Retrograde via nipple ducts (primary route)
2. Through nipple fissures and breaks in skin integrity
3. Hematogenous spread (rare, seen in septicemia)

Microbiome Dysbiosis Model: Recent 16S rRNA sequencing studies demonstrate that healthy breast milk contains a diverse bacterial community (Staphylococcus, Streptococcus, Corynebacterium, Lactobacillus, Bifidobacterium). Mastitis is associated with:

• Decreased bacterial diversity
• Overgrowth of S. aureus or S. epidermidis
• Depletion of beneficial commensals (Lactobacillus) [6,7]

This paradigm suggests that mastitis represents dysbiosis rather than simple infection, with therapeutic implications for probiotic intervention.

Pathology: Neutrophilic infiltration, microabscesses, epithelial necrosis, positive milk culture (> 10³ CFU/mL).

Clinical: Intense localized pain, marked erythema and induration, high fever (> 38.5°C), rigors, systemic toxicity.

Stage 4: Abscess Formation

Mechanism: Progressive tissue necrosis, liquefaction, and walling-off by fibrin and granulation tissue creates a localized pus collection.

Natural History:

• Occurs in 3-10% of mastitis cases if inadequately treated [8,9]
• Median time from mastitis onset: 7-10 days
• Risk increased by delayed antibiotic therapy and continued milk stasis

Pathology: Central necrotic cavity containing purulent material, surrounded by granulation tissue and fibrous capsule. Organisms identical to mastitis (predominantly S. aureus).

Clinical: Fluctuant mass, persistent fever despite antibiotics, exquisite focal tenderness, may have overlying skin thinning or "pointing."

Molecular and Cellular Pathophysiology

Immune Response

Innate Immunity:

• Toll-like receptor (TLR) activation by bacterial PAMPs (pathogen-associated molecular patterns)
• Complement activation and opsonization
• Neutrophil extracellular trap (NET) formation [13]

Adaptive Immunity:

• Th1 and Th17 responses dominate in bacterial mastitis
• B cell activation and immunoglobulin production
• Memory cell formation (relevant to recurrence)

Vascular Changes

• Inflammatory mediators (histamine, bradykinin, prostaglandins) increase vascular permeability
• Edema compresses lymphatic drainage → further stasis
• Increased blood flow → warmth and erythema

Pain Mechanisms

• Tissue distension activating mechanoreceptors
• Inflammatory mediators (PGE2, bradykinin) sensitizing nociceptors
• Nerve compression by edema

---

4. Clinical Presentation

Symptoms

Local Symptoms

• Breast Pain: Intense, throbbing, unilateral (occasionally bilateral)

  • "Character: Deep, aching, worse with touch or infant feeding"
  • "Distribution: Often follows anatomical segments (quadrants)"
  • "Severity: Typically severe enough to interfere with sleep and daily activities"

• Breast Lump: Palpable firmness or induration

  • "Shape: Classically wedge-shaped or segmental (following duct distribution)"
  • "Size: Variable, from 2-3 cm to entire quadrant"
  • "Consistency: Firm, non-fluctuant (fluctuance suggests abscess)"

• Nipple Symptoms:

  • Pain during latch or feeding
  • Visible cracks, fissures, or bleeding
  • "Milk blister" or bleb (white or yellow spot blocking duct opening)

Systemic Symptoms

• Constitutional "Flu-like" Illness:

  • "Fever: Typically 38.5-40°C, may have rigors"
  • "Malaise and fatigue: Profound exhaustion, difficulty caring for infant"
  • "Myalgias and arthralgias: Generalized body aches"
  • Headache
  • Nausea (less common)

• Onset: Often sudden, with fever preceding or coinciding with local symptoms (distinguishes from simple blocked duct)

• Severity Spectrum:

  • "Mild: Low-grade fever, minimal systemic symptoms (inflammatory mastitis)"
  • "Moderate: Fever > 38.5°C, significant malaise (bacterial mastitis)"
  • "Severe: High fever > 39°C, rigors, tachycardia (severe infection or early abscess)"

Signs

Inspection

• Erythema:

  • "Distribution: Wedge-shaped, segmental, or diffuse"
  • "Color: Pink to deep red"
  • "Extent: Variable, from small area to entire breast"
  • "Bilateral: Rare, should raise suspicion of systemic cause or inflammatory breast cancer"

• Skin Changes:

  • Shiny, taut skin overlying area of inflammation
  • Edema (peau d'orange texture is RED FLAG for inflammatory cancer)
  • Overlying skin thinning or discoloration (suggests underlying abscess)

• Nipple Examination:

  • Cracks, fissures, erosions
  • Milk blister (white or yellow plug at duct opening)
  • Purulent discharge from duct (rare, suggests deep infection)

Palpation

• Texture:

  • Firmness or induration in affected segment
  • Generalized breast engorgement vs. focal mass
  • "Fluctuance: Bouncy, compressible sensation in center of mass → ABSCESS (requires drainage)"

• Tenderness: Marked, often exquisite over affected area

• Temperature: Warmth over erythematous area

• Lymphadenopathy:

  • "Ipsilateral axillary nodes: Common, tender, mobile (reactive)"
  • "Fixed or matted nodes: RED FLAG (malignancy)"

Clinical Phenotypes

Blocked Duct (Ductal Narrowing)

• Focal, well-defined lump
• Minimal or no erythema
• No systemic symptoms, afebrile
• May see milk blister at nipple

Inflammatory Mastitis

• Wedge-shaped erythema and tenderness
• Fever (typically less than 38.5°C)
• Mild systemic symptoms
• Responds to milk removal alone without antibiotics

Bacterial Mastitis

• Marked erythema, warmth, induration
• High fever (> 38.5°C), rigors
• Significant systemic toxicity
• Requires antibiotics in addition to milk removal

Breast Abscess

• Fluctuant mass
• Persistent or worsening symptoms despite antibiotics
• High fever
• Requires drainage

Differential Diagnosis Clues

---

5. Clinical Examination

Systematic Breast Examination in Lactational Mastitis

Preparation

• Privacy: Ensure private, comfortable environment
• Positioning: Patient seated or semi-reclined, both breasts exposed
• Infant: May observe breastfeeding technique as part of assessment
• Chaperone: Offer chaperone (document if declined)

Inspection

Static Inspection (arms at sides):

• Overall breast symmetry and contour
• Skin changes: Erythema, edema, peau d'orange (RED FLAG)
• Nipple position, inversion, discharge
• Visible masses or distortion

Dynamic Inspection (arms raised, hands pressed on hips):

• Skin dimpling or tethering (suggests deeper pathology or malignancy)
• Movement symmetry

Specific Findings in Mastitis:

• Unilateral erythema (typically wedge-shaped or segmental)
• Shiny, taut skin from edema
• Nipple cracks, fissures, or milk blisters
• Purulent or bloody nipple discharge (rare, concerning)

Palpation

Technique:

• Use flat of fingers (not fingertips)
• Systematic quadrant-by-quadrant examination
• Include axillary tail
• Compress areola gently to assess for discharge

Normal Lactating Breast:

• Generalized firmness (engorgement)
• Nodular texture (lobular architecture)
• No discrete masses
• Non-tender or mildly tender

Pathological Findings:

Axillary Examination

• Tender, mobile lymphadenopathy: Reactive (common in mastitis)
• Fixed, hard nodes: RED FLAG (malignancy)
• Fluctuant axillary mass: Possible axillary abscess (rare complication)

Vital Signs

• Temperature: Fever > 38.5°C suggests bacterial mastitis
• Heart Rate: Tachycardia may indicate systemic infection or sepsis
• Blood Pressure: Hypotension is RED FLAG for sepsis

Observe Breastfeeding (If Possible)

Assessment of breastfeeding technique is therapeutic AND diagnostic:

• Latch: Deep latch vs. shallow (nipple trauma risk)
• Position: Infant alignment (ear-shoulder-hip), nose to nipple
• Suckling: Effective vs. ineffective (jaw movement, audible swallowing)
• Infant anatomy: Check for tongue tie (ankyloglossia), high palate, micrognathia
• Milk transfer: Does breast soften after feeding?

Red Flag Assessment (MUST NOT MISS)

Immediate Red Flags (Urgent/Emergency)

• Sepsis: Fever > 39°C, rigors, tachycardia > 100, hypotension, altered mental status → IV antibiotics, consider admission
• Necrotizing fasciitis: Rapidly spreading erythema (> 5 cm/hour), skin crepitus, severe pain out of proportion, systemic toxicity → EMERGENCY surgical referral
• Bilateral presentation: May indicate inflammatory breast cancer or systemic inflammatory condition

Red Flags Requiring Urgent Imaging/Referral (Within 48 Hours)

• Peau d'orange or skin dimpling
• Fixed, irregular mass
• Failure to improve after 48-72 hours of appropriate antibiotics
• Bloody nipple discharge
• Axillary lymphadenopathy with hard, fixed, or matted nodes

---

6. Investigations

General Principles

Lactational mastitis is a clinical diagnosis. The majority of cases do not require laboratory or imaging investigations. Testing is reserved for specific scenarios where the diagnosis is unclear, complications are suspected, or treatment failure occurs. [1,4]

Microbiology

Breast Milk Culture and Sensitivity

Indications (Academy of Breastfeeding Medicine recommendations): [4]

1. No clinical improvement after 48-72 hours of empiric antibiotics

   • Reassess diagnosis
   • Identify resistant organisms (MRSA)

2. Recurrent mastitis

   • Identify persistent or unusual organisms
   • Guide targeted antibiotic therapy

3. Hospital-acquired mastitis

   • Higher risk of MRSA and other nosocomial pathogens
   • Particularly if infant in NICU

4. Severe or systemic infection

   • Sepsis or toxic appearance
   • Consider blood cultures in addition to milk culture

5. Allergic to standard empiric therapy

   • Need for alternative agent guidance

Technique (Critical for Avoiding Contamination):

1. Clean nipple and areola with sterile water or saline (NOT antiseptic, which kills skin commensals)
2. Discard first few drops of milk
3. Express mid-stream sample into sterile container
4. Transport to laboratory within 2 hours or refrigerate

Interpretation:

• Bacterial Count: > 10³ CFU/mL considered significant (distinguishes infection from colonization)
• Common Isolates: S. aureus (60-80%), coagulase-negative staphylococci (10-20%), Streptococcus spp. (5-10%)
• MRSA: Increasing prevalence, particularly in hospital-acquired cases
• Culture-Negative Mastitis: Does NOT exclude bacterial infection (antibiotics already started, or inflammatory rather than infectious mastitis)

Blood Cultures

Indications:

• Sepsis or systemic toxicity
• Failure to respond to antibiotics
• Immunocompromised patient
• Suspicion of hematogenous spread

Yield: Low in uncomplicated mastitis; organisms typically identical to milk culture.

Imaging

Breast Ultrasound

Gold Standard Imaging Modality for lactating breast (mammography has limited sensitivity due to dense glandular tissue). [9,15]

Indications:

1. Suspected abscess:

   • Fluctuant mass on examination
   • Persistent fever despite 48-72 hours of antibiotics
   • Failure to improve with appropriate management

2. Palpable mass that persists after treatment:

   • Exclude underlying malignancy

3. Recurrent mastitis in same location:

   • Assess for anatomical abnormality, galactocele, or mass

4. Red flag features:

   • Peau d'orange, skin dimpling, or other signs concerning for malignancy

Ultrasound Findings:

Ultrasound-Guided Procedures:

• Needle aspiration: For abscess drainage (18-21 gauge needle, repeat as needed)
• Drain placement: Pigtail catheter for large or recurrent abscesses
• Core biopsy: For suspicious solid masses

Mammography

Role in Lactation: Limited due to increased breast density obscuring lesions. Reserved for specific scenarios.

Indications:

• Suspected malignancy (inflammatory breast cancer, mass)
• Persistent abnormality after cessation of lactation
• Follow-up of known lesion
• Typically performed AFTER ultrasound, not first-line

Technique: More challenging due to engorgement; may require gentle hand expression prior to imaging.

MRI

Rare Indications:

• Suspected inflammatory breast cancer when ultrasound and mammography inconclusive
• Complex anatomical abnormality
• Pre-operative planning for complex abscess

Laboratory Tests

Routine Blood Tests

NOT routinely indicated in uncomplicated mastitis. [1,4]

Consider in:

• Severe systemic infection or sepsis
• Immunocompromised patients
• Failure to respond to treatment

Tests:

• Full Blood Count (FBC/CBC):

  • Leukocytosis (WBC > 12,000/μL) supports bacterial infection
  • Neutrophilia with left shift
  • Normal WBC does NOT exclude infection

• C-Reactive Protein (CRP):

  • Elevated in bacterial mastitis (typically > 50 mg/L)
  • Useful to track treatment response

• Blood Glucose:

  • Diabetes is risk factor; check HbA1c if recurrent infections

• Lactate:

  • If sepsis suspected

Histopathology

Indications:

• Suspected inflammatory breast cancer
• Persistent mass after resolution of mastitis
• Atypical presentation

Technique:

• Core biopsy (ultrasound or stereotactic guidance)
• Fine needle aspiration cytology (FNAC) has lower sensitivity

---

7. Management

Overarching Principles

The foundation of mastitis management across the entire spectrum is effective and frequent milk removal. All other interventions are adjunctive. [4,5]

Management Algorithm

BREAST PAIN + ERYTHEMA ± FEVER
          ↓
    CLINICAL ASSESSMENT
    - Duration of symptoms
    - Severity (local vs systemic)
    - Examine for fluctuance
          ↓
    ┌─────────────┼─────────────┐
    ↓             ↓             ↓
BLOCKED DUCT  MASTITIS   SUSPECTED ABSCESS
(No fever,    (Fever,         (Fluctuance,
focal lump)   erythema,   persistent fever)
    ↓         systemic sx)      ↓
    ↓             ↓         URGENT US SCAN
    ↓             ↓             ↓
    └─────┬───────┴─────────────┘
          ↓
FIRST-LINE MANAGEMENT (ALL CASES)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
1. MILK REMOVAL (The Priority)
   • Continue breastfeeding (safe for baby)
   • Feed from affected side FIRST
   • Feed frequently (2-3 hourly)
   • Vary feeding positions
   • Hand express or pump if too painful
   • Ensure effective latch (lactation consult)
   
2. SUPPORTIVE MEASURES
   • Analgesia: Ibuprofen 400mg TDS
     (safe in breastfeeding, anti-inflammatory)
   • Paracetamol 1g QDS (additional if needed)
   • Cold packs POST-feed (reduce inflammation)
   • Warm packs PRE-feed (aid milk flow)
   • Gentle massage toward nipple during feeding
   • Rest and hydration
          ↓
    ANTIBIOTICS?
    ┌──────┴──────┐
    NO            YES
    ↓             ↓
Inflammatory  Bacterial Mastitis
Mastitis      (ANY of):
              • Fever > 24 hours
Manage with   • Systemic toxicity
milk removal  • Nipple fissure/crack
& supportive  • Failed conservative
measures        management (48h)
              • Recurrent mastitis
              • Culture-positive
              ↓
          ANTIBIOTIC CHOICE
          ┌────────┼────────┐
          ↓        ↓        ↓
    First-line  PCN allergy  Failed 1st
          ↓        ↓         line (48-72h)
          ↓        ↓         ↓
  FLUCLOXACILLIN  CEPHALEXIN  MILK CULTURE
  500mg QDS     500mg QDS   Consider MRSA
  10-14 days    10-14 days  ↓
    OR          OR         Vancomycin or
  DICLOXACILLIN CLARITHROMYCIN Linezolid
  500mg QDS    500mg BD    (ID consult)
          ↓
    REASSESS 48-72 HOURS
    ┌──────┴──────┐
IMPROVING    NOT IMPROVING
    ↓             ↓
Complete AB  • Check compliance
course       • Milk culture
Monitor      • US scan (abscess?)
             • Consider MRSA
             • Exclude IBC

Therapeutic Milk Removal (Cornerstone of Treatment)

Rationale

• Relieves ductal pressure
• Removes stagnant milk (bacterial culture medium)
• Prevents progression to abscess
• Maintains milk supply
• Continuation safe for infant (gastric acid kills bacteria; antibiotics in milk are therapeutic doses for infant) [4,5]

Technique

1. Optimize Breastfeeding:

• Frequency: Feed at least 8-12 times per 24 hours; every 2-3 hours from affected breast
• Affected Side First: Infant's suck is strongest at beginning of feed
• Positioning: Vary positions to drain all segments:
  • Cradle hold
  • Football/clutch hold (drains lateral segments)
  • Side-lying (comfortable when painful)
  • Dangle feeding (gravity-assisted, mother leans over infant)
• Duration: Allow infant to feed until breast soft (not time-limited)
• Latch Assessment: Deep latch (mouth wide, areola in mouth, not just nipple)

2. Adjunctive Expression (if infant cannot fully drain breast):

• Hand Expression: Technique:
  • Warm compress first
  • Massage from chest wall toward nipple
  • Thumb and fingers 2-3 cm from nipple base
  • Compress back toward chest wall, then together
  • Rotate around areola
• Pump: Hospital-grade double electric pump most effective
  • Use after breastfeeding to fully drain
  • Ensure correct flange size

3. Massage and Vibration:

• Gentle massage from affected area toward nipple during feeding
• Vibration (electric toothbrush on low setting over affected area) may help dislodge plugs

4. Address Mechanical Factors:

• Remove tight bras (use well-fitted, supportive nursing bra)
• Avoid prone sleeping
• Remove external pressure (seatbelts, heavy bags)

5. Lactation Consultant Referral:

• ALL women with mastitis benefit from expert assessment
• Identify and correct latch problems, tongue tie, positioning issues
• Provide ongoing support to prevent recurrence

Pharmacological Management

Analgesia and Anti-inflammatory Agents

First-Line: Ibuprofen

• Dose: 400-600 mg every 6-8 hours (maximum 2400 mg/24h)
• Rationale:
  • Analgesic
  • Anti-inflammatory (reduces edema and cytokine response)
  • Antipyretic
• Safety: Compatible with breastfeeding (minimal transfer to milk, less than 1% maternal dose)
• Evidence: Superior to paracetamol for inflammatory pain [1]

Second-Line: Paracetamol (Acetaminophen)

• Dose: 1000 mg every 6 hours (maximum 4000 mg/24h)
• Rationale: Analgesic and antipyretic (weak anti-inflammatory)
• Safety: Safe in breastfeeding
• Use: Combination with ibuprofen provides superior analgesia

Avoid: Aspirin (risk of Reye's syndrome in infant via breast milk, though minimal)

Antibiotic Therapy

Indications for Antibiotics (Academy of Breastfeeding Medicine, 2022): [4]

Antibiotics should be considered when:

1. Symptoms present > 24 hours with no improvement on conservative measures
2. Systemic symptoms: Fever, rigors, malaise
3. Nipple fissure or crack (portal of entry for bacteria)
4. Recurrent mastitis
5. Culture-positive milk (> 10³ CFU/mL)

Antibiotics NOT routinely required for:

• Blocked duct (no fever, focal lump only)
• Mild inflammatory mastitis less than 24 hours duration with conservative management

First-Line Agent: Flucloxacillin (UK, Australia, NZ) [1,4]

• Dose: 500 mg four times daily (QDS) for 10-14 days
• Mechanism: Beta-lactamase-resistant penicillin; bactericidal against S. aureus
• Coverage: Excellent anti-staphylococcal, also covers Streptococcus
• Safety in Lactation: Compatible; minimal milk transfer
• Compliance: Emphasize completing full course (shorter courses increase recurrence risk)

Alternative: Dicloxacillin (USA)

• Dose: 500 mg four times daily for 10-14 days
• Equivalent to flucloxacillin

Second-Line (Penicillin Allergy): [4]

Treatment Failure (No Improvement at 48-72 Hours):

1. Check compliance: Is patient taking antibiotics correctly?
2. Milk culture: Send for culture and sensitivity (if not already done)
3. MRSA coverage: Particularly if hospital-acquired, recurrent, or severe
   • Trimethoprim-sulfamethoxazole (co-trimoxazole): 160/800 mg BD
   • Doxycycline: 100 mg BD (avoid if infant less than 8 weeks due to teeth staining risk)
   • Linezolid or Vancomycin: Reserve for confirmed MRSA, ID consultation
4. Ultrasound: Exclude abscess
5. Reconsider diagnosis: Inflammatory breast cancer?

Duration: 10-14 days. Shorter courses (5-7 days) associated with higher recurrence rates. [1,4]

Safety in Breastfeeding: All recommended antibiotics are compatible with breastfeeding. Potential infant effects:

• Loose stools (disruption of infant gut microbiome)
• Oral candidiasis (thrush)
• Hypersensitivity reactions (rare)
• Benefits of continued breastfeeding outweigh theoretical risks [4]

Abscess Management

Breast abscess complicates 3-10% of mastitis cases. [8,9]

Diagnosis:

• Clinical: Fluctuant mass, persistent fever despite antibiotics
• Confirmed by ultrasound: Fluid collection

Treatment Paradigm Shift: Aspiration > Incision & Drainage [8,9,15]

First-Line: Ultrasound-Guided Needle Aspiration

Technique:

• Performed by interventional radiologist or trained surgeon
• Local anesthesia
• 18-21 gauge needle
• Aspirate to dryness under US guidance
• Send pus for culture and sensitivity
• Apply dressing

Advantages:

• Allows continued breastfeeding (no open wound)
• Minimal scarring
• No milk duct disruption (avoids milk fistula)
• Outpatient procedure
• Success rate: 60-80% with single aspiration [8,9]

Repeat Aspiration:

• If fluid re-accumulates (common), repeat aspiration every 2-3 days
• May require 2-4 aspirations for complete resolution
• Still superior to surgical drainage in most cases [15]

Second-Line: Catheter Drainage

Indications:

• Large abscess (> 5 cm)
• Recurrent re-accumulation after repeated aspirations

Technique:

• Pigtail catheter (8-12 French) placed under US guidance
• Left in situ until drainage less than 10 mL/24h
• Typically removed after 3-7 days

Advantage: Single procedure, continuous drainage

Disadvantage: Catheter discomfort, wound care, may interfere with breastfeeding

Third-Line: Incision and Drainage (I&D)

Reserved For:

• Multiloculated abscess not amenable to aspiration
• Failure of repeated aspirations and catheter drainage
• Necrotic tissue requiring debridement
• Suspected necrotizing fasciitis (EMERGENCY)

Technique:

• General or regional anesthesia
• Incision over point of maximum fluctuance
• Break down loculations with finger
• Copious irrigation
• Pack or leave drain
• Primary closure vs. secondary intention healing

Disadvantages:

• Open wound requiring dressing changes
• Scarring
• Risk of milk fistula
• Interruption of breastfeeding from affected breast
• Longer recovery

Post-Operative:

• Continue antibiotics 10-14 days
• Breastfeed from unaffected side
• Pump affected side to maintain supply and prevent engorgement
• Some women able to resume breastfeeding from affected side after wound heals

Adjunctive and Experimental Therapies

Probiotics

Rationale: Restore breast milk microbiome, competitive exclusion of pathogens. [6,7]

Evidence:

• Small RCTs suggest Lactobacillus fermentum or L. salivarius may reduce mastitis recurrence
• Mechanism: Repopulation of breast with beneficial commensals, immune modulation

Dose: Typically 10⁹-10¹⁰ CFU daily

Status: Promising but requires larger trials; not yet standard of care

Lecithin

Rationale: Emulsifying agent may reduce milk viscosity and prevent ductal plugging

Dose: 1200 mg 3-4 times daily

Evidence: Anecdotal and observational; no RCTs

Safety: Generally safe (food supplement)

Status: Commonly recommended for recurrent plugged ducts; weak evidence

Therapeutic Ultrasound

Rationale: Promote tissue healing, improve milk flow

Evidence: Limited; small studies show possible benefit for refractory mastitis

Availability: Requires specialized physiotherapy

---

8. Complications

Cessation of Breastfeeding

Most Common "Complication" and significant public health impact. [12]

Mechanism:

• Severe pain discourages feeding
• Fear that milk is "infected" or "harmful" to baby
• Healthcare provider advice to stop (INCORRECT)

Impact:

• Loss of benefits of breastfeeding for infant (immune, nutritional, developmental)
• Loss of benefits for mother (bonding, contraception, reduced cancer risk)
• Psychological impact (guilt, sense of failure)

Prevention:

• Education: Milk is safe for infant
• Emphasis that continued feeding is therapeutic
• Adequate analgesia
• Lactation support

Breast Abscess

Incidence: 3-10% of mastitis cases [8,9]

Risk Factors:

• Delayed antibiotic treatment
• Inadequate drainage (continued milk stasis)
• Premature cessation of antibiotics
• Virulent organisms (MRSA)

Management: See Abscess Management section above

Complications of Abscess:

• Milk fistula (particularly after I&D)
• Sepsis (rare)
• Scarring and cosmetic deformity

Recurrent Mastitis

Incidence: 5-10% [11]

Causes:

• Unresolved mechanical factors (persistent poor latch, tongue tie)
• Inadequate antibiotic duration
• Re-infection from infant nasopharynx (consider treating infant if recurrent S. aureus)
• Resistant organisms (MRSA)
• Underlying anatomical abnormality (duct ectasia, galactocele)
• Immunosuppression

Management:

• Thorough lactation assessment and correction of technique
• Milk culture and extended antibiotic course (14 days minimum)
• Consider infant swab (nares, throat) and treatment if S. aureus colonization
• Imaging (US) to exclude structural abnormality
• Consider probiotic supplementation
• Consider prophylactic lecithin

Candida Infection (Breast Thrush)

Risk: Increased after antibiotic use (disrupts normal flora) [16]

Presentation:

• Burning, shooting pain deep in breast (NOT surface)
• Pain during and AFTER feeding (persists between feeds)
• Nipple: Shiny, flaky, or normal appearance
• Infant: Often concurrent oral thrush (white plaques on tongue/buccal mucosa)

Treatment:

• Topical miconazole or clotrimazole to nipples after each feed
• Treat infant simultaneously (nystatin or miconazole oral gel)
• Oral fluconazole 150-200 mg loading, then 100 mg daily × 14 days for severe or recurrent cases
• Continue probiotics

Sepsis

Rare but Serious: Occurs in severe, untreated bacterial mastitis

Presentation: High fever > 39°C, rigors, tachycardia, hypotension, altered mental status

Management:

• Hospital admission
• IV antibiotics (flucloxacillin 1-2g QDS IV + gentamicin if severe)
• Fluid resuscitation
• Blood cultures
• Continue milk expression (IV oxytocin may aid drainage)
• Monitor infant (may require septic workup if maternal bacteremia)

Delayed Recognition of Inflammatory Breast Cancer

Critical Differential: Inflammatory breast cancer (IBC) can masquerade as mastitis [10]

Distinguish IBC:

• Tends to occur in non-lactating women OR bilateral
• Peau d'orange (hallmark finding)
• Skin dimpling, retraction
• Failure to respond to antibiotics
• Persistent mass
• May have lymphadenopathy

Action: ANY "mastitis" that fails to resolve after complete antibiotic course requires imaging and consideration of biopsy

Psychological Impact

Under-recognized: Mastitis is intensely painful and debilitating

Effects:

• Anxiety and distress
• Impact on mother-infant bonding
• Guilt if breastfeeding ceases
• Depression (particularly if recurrent)

Management:

• Empathy and validation
• Analgesia
• Support groups and counseling if needed
• Screen for postnatal depression

---

9. Prognosis and Outcomes

Natural History with Treatment

Uncomplicated Mastitis:

• Response Time: Clinical improvement typically within 48-72 hours of appropriate therapy (antibiotics + milk removal)
• Resolution: Complete resolution in 5-7 days in majority of cases
• Return to Normal Feeding: Usually within 1 week

Abscess:

• Aspiration Success: 60-80% cure with needle aspiration (may require 2-4 procedures) [8,9,15]
• Surgical Drainage: > 95% cure, but longer recovery and higher morbidity
• Time to Resolution: 2-4 weeks

Recurrence

Overall Recurrence: 5-10% [11]

Risk Factors for Recurrence:

• Inadequate initial treatment (antibiotic course less than 10 days)
• Persistent mechanical factors (unresolved latch problems)
• Infant colonization with S. aureus (source of re-infection)
• Immunosuppression

Prevention of Recurrence:

• Complete full antibiotic course
• Lactation consultant input
• Address infant oral anatomy issues (tongue tie release if indicated)
• Consider probiotic supplementation
• Lecithin for recurrent plugged ducts

Long-Term Outcomes

Breastfeeding Continuation:

• Women who receive adequate treatment and support typically able to continue breastfeeding successfully
• Those with abscess requiring I&D have higher rates of cessation

Breast Function:

• No long-term impact on breast function or subsequent lactation
• Scarring from I&D may affect cosmesis but rarely function

Cancer Risk:

• No evidence that mastitis increases breast cancer risk
• Important to exclude cancer masquerading as mastitis (IBC)

Prognostic Factors

Good Prognosis:

• Early presentation (less than 48 hours of symptoms)
• Prompt initiation of treatment (antibiotics + milk removal)
• Effective lactation support
• Compliance with treatment

Poor Prognosis (Higher Risk of Complications):

• Delayed presentation (> 1 week of symptoms)
• Premature cessation of breastfeeding
• Inadequate or incomplete antibiotic course
• Immunosuppression (diabetes, HIV)
• MRSA infection

---

10. Prevention

Primary Prevention (Preventing First Episode)

1. Optimal Breastfeeding Technique:

• Antenatal breastfeeding education
• Early postnatal lactation support (within 24-48 hours)
• Ensure effective latch and positioning
• Frequent, unrestricted feeding (8-12 times/24 hours)

2. Avoid Milk Stasis:

• Feed on demand (not scheduled)
• Avoid skipping feeds or rapid weaning
• Express if feeds missed or infant sleeping long stretches
• Avoid tight bras or external pressure

3. Nipple Care:

• Prevent nipple trauma (correct latch)
• Air-dry nipples after feeding
• Avoid harsh soaps (disrupt skin barrier)
• Lanolin or other emollient if dry/cracked

4. Address Infant Factors:

• Assess and treat tongue tie if present
• Treat infant oral candidiasis promptly

5. Maternal Health:

• Adequate rest and nutrition
• Manage stress
• Good hand hygiene

Evidence for Prevention: Cochrane review (2020) found that antenatal breastfeeding education and early postnatal lactation support reduce mastitis incidence. [5]

Secondary Prevention (Preventing Recurrence)

After First Episode:

1. Complete Full Antibiotic Course: Do not stop early even if symptoms resolve
2. Lactation Review: Identify and correct underlying mechanical factors
3. Infant Assessment: Consider swab for S. aureus and treatment if colonized
4. Ultrasound: If recurrent in same location, exclude structural abnormality
5. Probiotics: Consider Lactobacillus supplementation (evidence limited but safe)
6. Lecithin: 1200 mg TDS-QDS for recurrent plugged ducts

---

11. Evidence and Guidelines

Key Guidelines

Landmark Evidence

1. Spencer JP. Management of Mastitis in Breastfeeding Women. Am Fam Physician 2008. [1]

• Comprehensive review establishing standard management principles
• Emphasizes that antibiotics are adjunct to milk removal, not primary treatment
• Established flucloxacillin as first-line agent

2. Mitchell KB et al. Academy of Breastfeeding Medicine Clinical Protocol #36: The Mastitis Spectrum, Revised 2022. [4]

• Paradigm shift from discrete entities to spectrum model
• Evidence-based indications for antibiotics (> 24h symptoms, systemic features)
• Recommends needle aspiration over I&D for abscess
• Addresses emerging evidence on breast microbiome

3. Pileri P et al. Management of Breast Abscess during Breastfeeding. Int J Environ Res Public Health 2022. [15]

• Systematic review of abscess management
• Ultrasound-guided aspiration success rate 60-80%, repeat aspiration acceptable
• I&D should be reserved for complex cases
• Continued breastfeeding possible and beneficial even with abscess

4. Amir LH et al. Management of Mastitis in the Hospital Setting: An International Audit Study. J Hum Lact 2025. [17]

• International audit of mastitis management practices
• Significant variation in antibiotic prescribing and abscess management
• Highlights need for adherence to evidence-based guidelines

5. Crepinsek MA et al. Interventions for Preventing Mastitis After Childbirth (Cochrane Review). 2020. [5]

• Antenatal breastfeeding education reduces mastitis (RR 0.40)
• Early postnatal breastfeeding support reduces mastitis
• Probiotics show promise but require larger trials
• No evidence for acupuncture, prophylactic antibiotics

6. Arroyo R et al. Treatment of Infectious Mastitis during Lactation: Antibiotics versus Oral Administration of Lactobacilli. Clin Infect Dis 2010. [18]

• RCT comparing antibiotics to Lactobacillus for mastitis
• Lactobacillus fermentum or salivarius non-inferior to antibiotics for milk culture clearance
• Provides mechanistic support for probiotic therapy
• Requires confirmation in larger trials

7. Duan Z et al. Risk Factors for Treatment Failure in Lactational Mastitis: A Retrospective Cohort Study in China. Int Breastfeed J 2025. [16]

• Large retrospective cohort (n=487)
• Risk factors for treatment failure: delayed presentation, abscess at presentation, inadequate antibiotic duration
• Emphasizes importance of early treatment

---

12. Patient and Layperson Explanation

What is Mastitis?

Mastitis is inflammation of the breast tissue that commonly occurs when you are breastfeeding. It happens when milk gets blocked in the breast and doesn't drain properly. The blocked milk can then become infected with bacteria (usually from your skin or your baby's mouth), causing pain, redness, and swelling in the breast, along with flu-like symptoms such as fever, chills, and body aches.

Think of it like a blocked drain: when milk doesn't flow freely, it backs up, putting pressure on the breast tissue. This causes inflammation (swelling and pain). If bacteria get into the stagnant milk, it can become infected.

Is it Common?

Yes. About 1 in 5 breastfeeding mothers will experience mastitis at some point. It is most common in the first few weeks after birth when you and your baby are still learning to breastfeed effectively.

Should I Stop Breastfeeding?

Absolutely not. This is the most important thing to know. The BEST treatment for mastitis is to KEEP breastfeeding from the affected breast. Here's why:

1. Your milk is safe for your baby: The infection is in your breast tissue, not the milk itself. Your baby's stomach acid kills any bacteria. In fact, your breast milk contains antibodies that may help protect your baby.

2. Stopping makes it worse: If you stop feeding, the milk continues to build up, increasing pressure and making the infection worse. This can lead to a breast abscess (a pocket of pus) which is much harder to treat.

3. Feeding helps clear the infection: Your baby is the best "pump" for draining the blocked milk. Frequent feeding from the affected breast helps flush out the bacteria and relieves the pressure.

How Should I Feed?

• Feed frequently: Every 2-3 hours from the affected breast, even if it hurts (pain relief helps—see below).
• Affected side first: Your baby sucks strongest at the start of a feed, so start with the sore breast.
• Different positions: Try different feeding positions to drain all areas of the breast (cradle hold, football hold, lying on your side).
• Warmth before feeding: A warm flannel or shower before feeding can help milk flow.
• Massage gently: During feeding, gently massage the sore area toward the nipple—this helps move the blockage.
• Cool after feeding: A cold pack AFTER feeding can reduce swelling and pain.

What About Pain Relief?

• Ibuprofen (like Advil or Nurofen): 400-600 mg every 6 hours. This is safe during breastfeeding and is the best choice because it reduces inflammation (swelling) as well as pain and fever.
• Paracetamol (Tylenol): 1000 mg every 6 hours. Also safe and can be taken together with ibuprofen for severe pain.

Do not suffer in silence—adequate pain relief is essential and safe for your baby.

Do I Need Antibiotics?

Not always. If you catch it very early (within 24 hours) and your symptoms are mild, you may be able to clear it with frequent feeding and pain relief alone.

You SHOULD take antibiotics if:

• You have had symptoms for more than 24 hours
• You have a fever or feel very unwell (flu-like)
• You have cracks or sores on your nipple (bacteria can get in)
• Your symptoms are getting worse despite frequent feeding

Common antibiotic: Flucloxacillin (Floxapen, Fluclox) 500 mg four times a day for 10-14 days.

Important:

• These antibiotics are safe during breastfeeding.
• Your baby might have slightly looser stools—this is normal and not harmful.
• Finish the WHOLE course even if you feel better, to prevent it coming back.

What if I Develop a Lump or it's Not Getting Better?

If you have a firm lump in your breast that feels "bouncy" or fluid-filled (called an abscess), or if you are not improving after 2-3 days of antibiotics, contact your doctor urgently. You may need:

• An ultrasound scan of your breast
• Drainage of the abscess with a needle (done under local anesthetic)

Good news: Modern treatment for breast abscess is usually a simple needle procedure (like having blood taken), NOT surgery. You can usually continue breastfeeding even with an abscess.

How Can I Prevent it Happening Again?

• Get breastfeeding help early: See a lactation consultant or breastfeeding specialist to check your baby's latch and positioning.
• Feed frequently and on demand: Don't skip feeds or let your breasts get too full.
• Avoid tight bras: Wear a well-fitting, supportive nursing bra (no underwires).
• Rest and look after yourself: Tiredness and stress make mastitis more likely.
• Treat any nipple cracks promptly: Use lanolin cream and seek help with latch.
• Check your baby's mouth: Some babies have tongue tie, which affects feeding—this can be treated.

When Should I Seek Urgent Help?

Contact your doctor or midwife urgently if:

• You have a very high fever (> 39°C/102°F) or feel extremely unwell
• The redness is spreading rapidly
• You have a lump that is getting bigger or feels like it has fluid in it
• You are not improving after 48 hours of antibiotics
• The skin looks dimpled or like orange peel (rare but important)

Key Message

Mastitis is common, painful, but very treatable. The key is to KEEP BREASTFEEDING, take pain relief, and use antibiotics if needed. With the right treatment and support, most women are back to normal within a week and can continue breastfeeding successfully.

You are not alone, and help is available. Don't hesitate to reach out to your midwife, doctor, or lactation consultant.

---

13. Examination Focus (MRCOG, Medical Finals, OSCE)

High-Yield Exam Topics

1. First-Line Management

Question: "A woman presents 2 weeks postpartum with unilateral breast pain, erythema, and fever. What is the MOST important initial management?"

Model Answer: The most important initial management is continued breastfeeding with frequent milk removal from the affected breast. This is the cornerstone of treatment across the mastitis spectrum. Milk removal relieves ductal pressure, drains stagnant milk (which acts as bacterial culture medium), and prevents progression to abscess. Additional measures include analgesia (ibuprofen for anti-inflammatory effect) and supportive measures (warm compress pre-feed, cold compress post-feed). Antibiotics (flucloxacillin) are indicated if symptoms present > 24 hours, systemic features, or nipple fissure present. The mother should be reassured that continuing breastfeeding is safe for the infant and therapeutic.

2. Antibiotic of Choice

Question: "What is the first-line antibiotic for lactational mastitis and why?"

Model Answer: Flucloxacillin 500 mg four times daily for 10-14 days (or dicloxacillin in the USA). The causative organism is Staphylococcus aureus in 60-80% of cases. S. aureus produces beta-lactamase, rendering amoxicillin and ampicillin ineffective. Flucloxacillin is a beta-lactamase-resistant penicillin with excellent anti-staphylococcal coverage, is safe in lactation (minimal transfer to breast milk), and is well-tolerated. Alternative agents for penicillin allergy include cephalexin, clarithromycin, or erythromycin. A full 10-14 day course is essential to prevent recurrence.

3. Management of Breast Abscess

Question: "How should a breast abscess complicating lactational mastitis be managed?"

Model Answer: The first-line management of lactational breast abscess is ultrasound-guided needle aspiration rather than incision and drainage (I&D). Needle aspiration allows:

• Continuation of breastfeeding (no open wound)
• Minimal scarring
• Avoidance of milk duct injury (preventing milk fistula)
• Outpatient procedure

Success rate is 60-80% with single aspiration; repeat aspirations every 2-3 days are acceptable and still superior to I&D. Pigtail catheter drainage is an alternative for large or recurrent collections. Surgical I&D is reserved for multiloculated abscesses not amenable to aspiration or failed needle/catheter drainage. Concurrent antibiotics (flucloxacillin) and continued milk removal are essential adjuncts. Pus should be sent for culture and sensitivity.

4. Differential Diagnosis

Question: "A 35-year-old presents with unilateral breast erythema and peau d'orange skin changes. She was diagnosed with 'mastitis' 3 weeks ago but has not improved with antibiotics. What is the most important differential diagnosis?"

Model Answer: Inflammatory breast cancer (IBC). IBC is a rare but aggressive form of breast cancer that presents with breast erythema, peau d'orange (orange-peel skin texture from dermal lymphatic invasion), and may mimic mastitis. Key features distinguishing IBC from mastitis:

• Occurs more commonly in non-lactating women
• Peau d'orange is pathognomonic for IBC
• Failure to respond to appropriate antibiotics within 72 hours
• May be bilateral
• Persistent or progressive symptoms

ANY "mastitis" that fails to resolve after a complete course of antibiotics requires urgent imaging (mammography and ultrasound) and biopsy. IBC requires urgent oncology referral for staging and neo-adjuvant chemotherapy.

5. Safety of Breastfeeding

Question: "Is it safe to continue breastfeeding during mastitis? Justify your answer."

Model Answer: Yes, it is safe and essential to continue breastfeeding during mastitis.

Safety for infant:

• Bacteria (S. aureus) are killed by gastric acid in infant's stomach
• Antibiotics (flucloxacillin) in breast milk are in sub-therapeutic doses and safe
• Breast milk contains maternal antibodies that may be protective
• No evidence of harm to infant from feeding during mastitis

Therapeutic benefit:

• Milk removal is the PRIMARY treatment for mastitis
• Effective drainage relieves ductal pressure and removes bacterial culture medium
• Cessation of feeding leads to milk stasis, increased pressure, and progression to abscess
• Infant's suckling is more effective than pumping for milk removal

Evidence: Academy of Breastfeeding Medicine (2022) states continued breastfeeding is the cornerstone of management. Cessation of breastfeeding is the most common complication and has adverse consequences for mother and infant.

OSCE Station: Lactational Mastitis

Scenario: You are the GP. A 28-year-old primiparous woman presents 3 weeks postpartum with right breast pain and fever for 24 hours. Assess and manage.

Mark Scheme:

History (25 marks):

• Onset and duration of symptoms
• Breast symptoms: pain (severity, location), lump, erythema
• Systemic symptoms: fever (measure), rigors, malaise
• Breastfeeding history: frequency, effectiveness, latch problems, nipple trauma
• Previous episodes
• Obstetric history: parity, mode of delivery
• Current medications
• Red flags: rapidly spreading erythema, fluctuance, bilateral symptoms

Examination (25 marks):

• Vital signs (temperature, pulse)
• Inspection: erythema (wedge-shaped?), peau d'orange (RED FLAG), nipple cracks
• Palpation: tenderness, induration, fluctuance (abscess?)
• Axillary lymph nodes
• Observe breastfeeding technique (if time/appropriate)

Management Plan (30 marks):

• Explain diagnosis
• Emphasize continued breastfeeding (most important)
  • Feed from affected side first
  • Frequent feeding (2-3 hourly)
  • "Techniques: warm compress pre-feed, massage toward nipple, vary positions"
• Analgesia: Ibuprofen 400 mg TDS (safe in breastfeeding)
• Antibiotics: Flucloxacillin 500 mg QDS × 10-14 days (symptoms > 24h, systemic features present)
• Safety of antibiotics in breastfeeding
• Supportive: rest, hydration
• Lactation consultant referral

Safety Netting (10 marks):

• Review in 48-72 hours (or earlier if worsening)
• Red flags: worsening symptoms, fluctuant lump (abscess), failure to improve (consider imaging)
• Complete antibiotic course to prevent recurrence

Communication (10 marks):

• Empathy
• Clear explanation
• Reassurance about breastfeeding safety
• Check understanding

Viva Voce Topics

1. Why is needle aspiration preferred over incision and drainage for breast abscess?

Incision and drainage (I&D) was historically standard but has several disadvantages:

• Cuts milk ducts → risk of milk fistula
• Open wound → painful dressing changes, scarring
• Disrupts breastfeeding from affected breast
• Longer recovery
• Requires general anesthesia (usually)

Needle aspiration:

• Minimally invasive (outpatient, local anesthesia)
• Preserves ducts → allows continued breastfeeding
• Minimal scarring
• Can be repeated if re-accumulation occurs
• Success rate 60-80%, equivalent to or better than I&D in most studies

I&D reserved for: multiloculated complex abscesses, failed aspiration, necrotic tissue requiring debridement.

2. Explain the microbiome paradigm in mastitis pathophysiology.

Traditional view: Breast milk is sterile; mastitis is bacterial infection via nipple fissures.

Modern view: Breast milk contains diverse microbiome (Staphylococcus, Streptococcus, Lactobacillus, Corynebacterium). Mastitis represents dysbiosis (imbalance) rather than de novo infection.

Evidence:

• 16S rRNA sequencing shows decreased diversity in mastitis
• Overgrowth of S. aureus or S. epidermidis
• Depletion of beneficial commensals (Lactobacillus)

Therapeutic implications:

• Probiotics (Lactobacillus fermentum, L. salivarius) may restore balance
• Small RCTs show benefit in recurrent mastitis
• Mechanism: Competitive exclusion of pathogens, immune modulation

Status: Promising area; requires larger trials before routine recommendation.

3. When should you refer a patient with "mastitis" urgently to breast surgery or oncology?

Red flags requiring urgent referral (within 2 weeks):

1. Peau d'orange or skin dimpling: Hallmark of inflammatory breast cancer (IBC)
2. Failure to respond to antibiotics within 48-72 hours: Consider abscess (needs imaging/drainage) or IBC
3. Persistent mass after resolution of inflammation: Exclude malignancy
4. Bilateral presentation: Unusual for mastitis; consider IBC or systemic cause
5. Non-lactating woman with "mastitis" symptoms: IBC more common than mastitis in non-lactating women
6. Bloody nipple discharge: Concerning for duct papilloma or malignancy
7. Fixed axillary lymphadenopathy: Suspicious for malignancy

Investigation: Ultrasound ± mammography ± core biopsy. Do not delay imaging in presence of red flags.

---

14. References

Primary Sources

1. Spencer JP. Management of mastitis in breastfeeding women. Am Fam Physician. 2008;78(6):727-731. PMID: 18819238.

2. Scott DM. Inflammatory diseases of the breast. Best Pract Res Clin Obstet Gynaecol. 2022;83:64-77. doi:10.1016/j.bpobgyn.2021.11.013. PMID: 34991976.

3. Blackmon MM, Nguyen H, Mukherji P. Acute Mastitis. StatPearls. Updated 2025. PMID: 32491714.

4. Mitchell KB, Johnson HM, Rodríguez JM, et al. Academy of Breastfeeding Medicine Clinical Protocol #36: The Mastitis Spectrum, Revised 2022. Breastfeed Med. 2022;17(5):360-376. doi:10.1089/bfm.2022.29207.kbm. PMID: 35576513.

5. Crepinsek MA, Taylor EA, Michener K, Stewart F. Interventions for preventing mastitis after childbirth. Cochrane Database Syst Rev. 2020;9(9):CD007239. doi:10.1002/14651858.CD007239.pub4. PMID: 32987448.

6. Delgado S, Arroyo R, Jiménez E, et al. Mastitis infectious: etiology, diagnosis, and antimicrobial treatment. Enferm Infecc Microbiol Clin. 2009;27(5):325-336. [Microbiome in mastitis].

7. Mediano P, Fernández L, Rodríguez JM, Marín M. Case-control study of risk factors for infectious mastitis in Spanish breastfeeding women. BMC Pregnancy Childbirth. 2014;14:195.

8. Pileri P, Sartani A, Mazzocco MI, et al. Management of Breast Abscess during Breastfeeding. Int J Environ Res Public Health. 2022;19(9):5762. doi:10.3390/ijerph19095762. PMID: 35565158.

9. Kulkarni D. Clinical Presentations of Breast Disorders in Pregnancy and Lactation. Adv Exp Med Biol. 2020;1252:31-37. doi:10.1007/978-3-030-41596-9_5. PMID: 32816260.

10. Taghian NR, Miller CL, Jammallo LS, O'Toole J, Skolny MN. Lymphedema following breast cancer treatment and impact on quality of life: a review. Crit Rev Oncol Hematol. 2014;92(3):227-234. [Inflammatory breast cancer differential].

11. Amir LH, Lumley J, Garland SM. A failed RCT to determine if antibiotics prevent mastitis: Cracked nipples colonized with Staphylococcus aureus. BMC Pregnancy Childbirth. 2004;4:19. PMID: 15369597.

12. Amir LH, Crawford SB, Cullinane M, et al. General practitioners' management of mastitis in breastfeeding women: a mixed method study in Australia. BMC Prim Care. 2024;25(1):175. doi:10.1186/s12875-024-02414-4. PMID: 38730361.

13. Riordan JM, Nichols FH. A descriptive study of lactation mastitis in long-term breastfeeding women. J Hum Lact. 1990;6(2):53-58. [Inflammatory pathophysiology].

14. Stafford I, Hernandez J, Laibl V, et al. Community-acquired methicillin-resistant Staphylococcus aureus among patients with puerperal mastitis requiring hospitalization. Obstet Gynecol. 2008;112(3):533-537. [MRSA in mastitis].

15. Ulitzsch D, Nyman MK, Carlson RA. Breast abscess in lactating women: US-guided treatment. Radiology. 2004;232(3):904-909. [Ultrasound-guided aspiration evidence].

16. Duan Z, Xiao Q, Zhou J, et al. Risk factors for treatment failure in lactational mastitis: a retrospective cohort study in China. Int Breastfeed J. 2025;20(1):13. doi:10.1186/s13006-025-00774-w. PMID: 41219775.

17. Amir LH, Coca KP, Mello Da Silva MJ, et al. Management of Mastitis in the Hospital Setting: An International Audit Study. J Hum Lact. 2025. doi:10.1177/08903344251338245. PMID: 40437779.

18. Arroyo R, Martín V, Maldonado A, Jiménez E, Fernández L, Rodríguez JM. Treatment of infectious mastitis during lactation: antibiotics versus oral administration of Lactobacilli isolated from breast milk. Clin Infect Dis. 2010;50(12):1551-1558. [Probiotic evidence].

Guidelines

• NICE Clinical Knowledge Summaries: Mastitis and Breast Abscess. Updated 2022. Available at: https://cks.nice.org.uk/topics/mastitis-breast-abscess/
• WHO: Guideline: Counselling of Women to Improve Breastfeeding Practices. Geneva: World Health Organization; 2018.
• Royal College of Obstetricians and Gynaecologists (RCOG): Best Practice in Labour and Delivery (includes breastfeeding support). 2020.

---

Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances and be made in consultation with appropriate specialists. Always refer to current local guidelines and protocols. This content is designed to support clinical learning and examination preparation (MRCOG, MRCP, medical finals, OSCE) but does not replace clinical judgment or direct patient care training.